| Literature DB >> 34062978 |
Michelle McCormack1, Anita Talbot1, Eugene Dillon2, Ian O'Connor1, Eugene MacCarthy1.
Abstract
In aquaculture, recurrence rates of amoebic gill disease (AGD) caused by the ectoparasite Paramoeba perurans are high and no prophylactic strategies exist for disease prevention. In this study, Atlantic salmon (Salmo salar) were initially inoculated with P. perurans and following the development of amoebic gill disease were treated with freshwater immersion on day 21 and day 35 post inoculation. Fish were re-inoculated following a negative qPCR analysis for the presence of P. perurans. The gill host immune response was investigated at 7, 14, and 18 days post re-inoculation. Differential proteome expression of immune related proteins was assessed by comparison of each time point against naïve controls. In the gill, some proteins of the innate immune system were expressed in response to gill re-colonization by P. perurans, while no features of adaptive immunity were found to be differentially expressed. Many of the proteins identified are novel in the context of AGD and their expression profiles suggest that their roles in the response to disease development and progression in single or multiple infections warrant further investigation.Entities:
Keywords: amoebic gill disease; gill proteome; immune response; repeat inoculation
Year: 2021 PMID: 34062978 PMCID: PMC8147987 DOI: 10.3390/microorganisms9050993
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Experimental design of trial investigating the host response to repeat infection with P. perurans. Fish were acclimatized for 7 days. Immediately prior to the initial P. perurans inoculation, naïve control fish were sampled (T0). AGD was confirmed by gill score analysis 21 days after inoculation and fish were treated by freshwater immersion. Some features of AGD persisted 14 days after freshwater treatment, and the freshwater immersion was repeated. Fish health was confirmed by gross gill analysis 14 days after the second freshwater treatment, and fish were sampled prior to re-infection with P. perurans (T1). Fish were sampled at 7 (T2), 14 (T3) and 18 (T4) days post re-infection.
Figure 2Distribution of gill scores from fish sampled 7 days (T2), 14 days (T3), and 18 days (T4) post re-infection.
Figure 3Heatmap plot of the proteins exhibiting t-test differences of at least +/− 1.5 in (A) control (T0) and post freshwater treatment samples (T1), (B) control (T0) and 7 days post re-infection samples (T2), (C) control (T0) and 14 days post re-infection samples (T3) and (D) control (T0) and 18 days post re-infection samples (T4) after LFQ values were z-score normalized. Hierarchical clustering was performed using Euclidian distance and average linkage using the Perseus software.
Immune-related proteins differentially expressed in the gills of P. perurans inoculated salmon after freshwater treatment for initial P. perurans infection (T1) and at three timepoints post re-infection (T2, T3, and T4). Proteins were identified by mass spectrometry and analysis was performed by Max Quant and Perseus computational platforms. For each time point protein expressions were compared to naïve controls (T0). Reported fold change values were obtained by calculating the difference between the mean log2 transformed values for the two compared conditions (p value < 0.05).
| Name | Uniprot Id | T0 v T1 | T0 v T2 | T0 v T3 | T0 v T4 | No. of Peptides |
|---|---|---|---|---|---|---|
| Alpha-1-antitrypsin homolog | A0A1S3SAE4 | 1.34 | 1.56 | 18 | ||
| Alpha-1-antitrypsin-like | A0A1S3PJ46 | 1.90 | 2.35 | 2.40 | 2.56 | 5 |
| Alpha-2-macroglobulin-like | A0A1S3SY27 | 1.67 | 1.59 | 2.08 | 37 | |
| Alpha-2-macroglobulin-like isoform X2 | A0A1S3SY28 | 2.09 | 1.94 | 2.22 | 19 | |
| Apolipoprotein A-I precursor | B5XBH3 | 1.32 | 1.66 | 2.28 | 2.28 | 29 |
| Apolipoprotein A-IV | B5X8U6 | 2.57 | 3.47 | 4.09 | 4.58 | 15 |
| Apolipoprotein B-100 isoform X4 | A0A1S3M896 | 3.11 | 2.62 | 3.60 | 61 | |
| Apolipoprotein C-I isoform X1 | A0A1S3RYY8 | 3.23 | 2.63 | 4 | ||
| Apolipoprotein C-I-like | A0A1S3N6L4 | 1.53 | 7 | |||
| Coagulation factor VII-like | A0A1S3MXK4 | 1.80 | 1.53 | 15 | ||
| Coagulation factor XIII B chain-like isoform X1 | A0A1S3QZV0 | 1.41 | 1.59 | 1.53 | 15 | |
| Complement C3 | A0A1S3QRL5 | 1.30 | 1.58 | 96 | ||
| Complement C3-like | A0A1S3L7F1 | 1.80 | 1.66 | 1.99 | 2.35 | 35 |
| Complement C3-like | A0A1S3PMF1 | 1.40 | 2.01 | 23 | ||
| Complement C4-B-like | A0A1S3NRS7 | 2.85 | 1.77 | 9 | ||
| Complement C5 | A0A1S3PRG9 | 1.96 | 1.73 | 1.93 | 2.43 | 41 |
| Complement factor H-like | A0A1S3QR20 | 1.51 | 1.89 | 1.81 | 2.02 | 47 |
| Complement factor I-like | A0A1S3QGL8 | 2.11 | 8 | |||
| E3 ubiquitin/ISG15 ligase TRIM25-like isoform X6 | A0A1S3L7B4 | 2.80 | 2.52 | 3 | ||
| Fish-egg lectin precursor | B5X7U2 | 1.96 | 6 | |||
| Gtpase IMAP family member 7-like | B9ENC9 | −2.33 | −1.93 | 4 | ||
| Hemagglutinin/amebocyte aggregation factor-like isoform X1 | A0A1S3MZH7 | 2.38 | 1.71 | 4 | ||
| Hemopexin | A0A1S3MVQ2 | 1.53 | 1.43 | 22 | ||
| Hemopexin | A0A1S3PQV6 | 1.73 | 28 | |||
| Histidine-rich glycoprotein-like | A0A1S3KK24 | 1.54 | 20 | |||
| Hyaluronan-binding protein 2 isoform X2 | A0A1S3N344 | 2.12 | 1.69 | 1.83 | 2.18 | 13 |
| Plasma protease C1 inhibitor-like | A0A1S3SJI8 | 1.37 | 1.55 | 13 | ||
| Plasminogen | A0A1S3MAB2 | 1.32 | 1.84 | 19 | ||
| Proteasome activator complex subunit 2 | B5X6E1 | −1.58 | 10 | |||
| Protein AMBP isoform X1 | A0A1S3LTS1 | 1.50 | 10 | |||
| Type-4 ice-structuring protein | B5X6Y1 | 2.08 | 4 | |||
| Type-4 ice-structuring protein LS-12 | B5XDA4 | 3.19 | 4.76 | 4.79 | 5.88 | 9 |